comprehensive -WSS

comprehensive

author：leisure time 2025-09-29 21:20:50 - browse：7

Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT — Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

hotspot

Wikipedia

WSS

Peter Marks talks Operation Warp Speed for Rare Diseases

Cancer cells are shown to suck energy source from immune cells

How doctors and nurses shape Google's AI

How doctors and nurses shape Google's AI

How should state employee insurance handle Wegovy?

Wellcome Trust names Røttingen as its new CEO

focus

comprehensive

focus

In Memoriam: Notable people who died in 2023

Cancer cells are shown to suck energy source from immune cells

State Dept. review finds Biden bears some blame for Afghanistan failures

Humana CEO Bruce Broussard to step down in 2024

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Medical leaders decry Supreme Court decision on affirmative action

Nick Jonas talks about managing diabetes along with his career

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Takeaways from AdvaMed, the largest medical devices conference

hotspot

European regulators consider appeal over Amylyx ALS drug

Akero's treatment for NASH falls short in cirrhosis study

Better Therapeutics data on benefit with GLP

Life sciences deals on track to hit lowest point since 2017

Female surgeons have lower rates of long

Readout LOUD podcast: Merger Mondays, Ozempic panic

Wikipedia

hotspot

Wikipedia

leisure time